Edgewell Sells Feminine Care Business to Essity

Edgewell Personal Care has completed the sale of its feminine care business to Essity for US$340 million, closing a transaction that reshapes its portfolio as the company prioritizes debt reduction and investment in shaving, sun and skin care, and grooming.

“Completing the sale of our Feminine Care business is a pivotal step in Edgewell’s transformation,” says Rod Little, President and CEO, Edgewell Personal Care, pointing to the company’s intent to simplify operations and focus capital and management attention on its core categories. He says that the proceeds are expected to strengthen the balance sheet, support debt repayment, and fund reinvestment in brands and innovation, while employees in the divested unit transition to Essity, a Sweden-based health and hygiene company.

The divestment reflects a broader trend among consumer goods companies to streamline portfolios in response to competitive pressures, cost volatility, and investor demands for clearer strategic focus. Edgewell, headquartered in Shelton, Connecticut, says net proceeds from the transaction, after taxes and transaction costs, will be used primarily to pay down the balance of its US revolving credit facility while continuing to invest in long-term growth initiatives. By exiting feminine care, the company reduces exposure to a category characterized by intense competition, pricing pressure, and rising marketing and input costs.

At the same time, the sale comes as feminine hygiene and intimate care products remain the subject of increasing attention from public health organizations, policymakers and employers. The World Health Organization (WHO) and the UN Special Program on Human Reproduction have identified menstrual health as a priority issue, citing its links to women’s health, gender equality, and the well-being of adolescent girls. Despite that focus, understanding of menstruation in workplace settings remains uneven, with many employers lacking policies or resources to address the needs of women during their menstrual cycles.

This evolving social and regulatory backdrop adds context to Essity’s acquisition. Feminine care products are no longer viewed solely as consumer staples but are increasingly connected to broader discussions about workplace inclusion and employee well-being. In several markets, these discussions have begun to influence labor policy and corporate practices.

Edgewell says it will work with Essity to ensure continuity for employees, customers, and consumers during the transition. The companies entered into a transition services agreement under which Edgewell will provide support across accounting, information technology, quality assurance, operations, supply chain, and sales for at least one year after closing. Such agreements are common in carve-out transactions and are intended to allow the buyer time to integrate systems and processes while maintaining service levels.

From a reporting standpoint, Edgewell plans to classify the feminine care business as a discontinued operation. The company says it will file unaudited pro forma condensed consolidated financial information prepared under Article 11 of Regulation S-X in a Current Report on Form 8-K on or before Feb. 6. Additional supplemental information is expected during Edgewell’s first-quarter fiscal 2026 earnings call on Feb. 9, offering investors insight into the company’s post-transaction financial profile.

The acquisition gives Essity additional scale in a market that continues to show growth potential. According to a 2025 report by Allied Market Research, the global feminine intimate care market was valued at about US$7.8 billion in 2024 and is projected to reach US$14 billion by 2034, expanding at a compound annual growth rate of 6.1% from 2025 to 2034. Growth drivers cited in the report include rising awareness of personal hygiene, higher disposable incomes, and increasing consumer preference for organic and natural products, along with the expansion of online retail channels.

The report identifies cleansing liquids as the largest product segment, accounting for nearly half of market revenue in 2024, while oils are expected to see the fastest growth as interest increases in natural and soothing formulations. Offline channels such as supermarkets, pharmacies, and specialty stores continue to dominate sales, though online retail is projected to grow faster due to convenience, discreet purchasing options and subscription models. North America holds the largest market share, while regions including Latin America, the Middle East, and Africa are expected to post higher growth rates over the next decade.

Against this backdrop, Essity’s expansion in feminine care aligns with its broader focus on health and hygiene categories with recurring demand. For Edgewell, the sale marks a strategic exit from a growing but competitive market in favor of concentrating on fewer categories where it believes it can achieve stronger differentiation and operational efficiency.

Broader societal developments also frame the transaction. Research cited by media outlets has linked discrimination and lack of support around menstruation to higher risks of depression during menstrual cycles, while conditions such as dysmenorrhea are estimated to affect a large proportion of women at some point in their lives. In Mexico, lawmakers have proposed amendments to federal labor laws that would grant up to two days of paid leave per month to individuals experiencing debilitating menstrual conditions, pending approval by Congress. Similar policy discussions have emerged in other countries, reflecting a gradual shift toward addressing menstrual health in workplace and labor frameworks.

Edgewell cautions that statements regarding anticipated benefits of the transaction, use of proceeds, and future performance are forward-looking and subject to risks, including competition, customer concentration, execution challenges and fluctuations in raw material, labor, and transportation costs. As the company completes the transition and reports updated financials, attention will turn to how effectively a narrower portfolio translates into operating performance and how Essity integrates and grows the acquired feminine care business within a market that continues to evolve economically and socially.